Hanseatic Management Services’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-132
Closed -$37K 109
2022
Q4
$37K Buy
+132
New +$37.3K 0.09% 54
2015
Q2
Sell
-4,080
Closed -$1.72M 394
2015
Q1
$1.72M Buy
+4,080
New +$1.61M 0.92% 37
2014
Q4
Sell
-3,054
Closed -$1.01M 315
2014
Q3
$1.01M Buy
3,054
+2,921
+2,196% +$963K 0.54% 79
2014
Q2
$42K Sell
133
-2,007
-94% -$604K 0.03% 141
2014
Q1
$7K Sell
2,140
-4,686
-69% -$1.49M 0.21% 93
2013
Q4
$1.91M Buy
6,826
+4,584
+204% +$1.19M 1.21% 11
2013
Q3
$540K Sell
2,242
-14,836
-87% -$3.32M 0.36% 84
2013
Q2
$3.67M Buy
+17,078
New +$3.65M 2.21% 4

Other funds holding BIIB

Hanseatic Management Services's BIIB Position: Q1 2023 in Review

Hanseatic Management Services sold out of Biogen (BIIB) in Q1 2023, closing a stake of 132 shares — an estimated $37K sold.

Hanseatic Management Services first reported a position in BIIB in Q2 2013 and held it in 8 quarters. The position peaked at $3.67M in Q2 2013. 1,001 funds tracked by Wall St. Rank hold BIIB as of Q1 2023.

  • Hanseatic Management Services reported no remaining Biogen position as of Q1 2023 after selling out during the quarter.
  • Hanseatic Management Services sold 132 Biogen shares in Q1 2023, an estimated $37K.
  • Hanseatic Management Services first reported a position in Biogen in Q2 2013 and held it in 8 quarters.
  • Hanseatic Management Services's Biogen position peaked at $3.67M in Q2 2013.
  • 1,001 funds tracked by Wall St. Rank held Biogen as of Q1 2023.

Based on Hanseatic Management Services's 13F filing for Q1 2023, filed 12 May 2023.